BACKGROUND. The objective of this study was to establish prognostic fa
ctors for thymoma and determine the impact of surgery with or without
postoperative radiotherapy. METHODS, Seventy patients treated at the U
niversity Hospital Dusseldorf during the period 1954-1991 were retrosp
ectively studied. AU thymoma patients underwent surgery, 22 received p
ostoperative radiotherapy, and 3 also received chemotherapy. According
to thymoma staging as described previously by Masaoka et al., 21% wer
e Stage I, 26% Stage II, 43% Stage III, 7% Stage TVA, and 3% Stage IVB
. Lymphocytic type disease was found in 36% of patients, lymphoepithel
ial type in 33%, epithelial type in 23%, and spindle cell type in 9%.
The relevance of Karnofsky performance status (KPS), gender, age, myas
thenia gravis, histology, tumor size, and stage to survival was determ
ined by univariate analysis, and their independent significance was te
sted by multivariate analysis. Survival rates were calculated using th
e Kaplan-Meier method and the log rank lest. RESULTS. In univariate an
alysis, KPS (P < 0.001), histologic type (P = 0.0093), and stage (P =
0.0001) proved to be significant predictors of overall survival. Spind
le cell type was associated with the best and epithelial type the wors
t prognosis; patients with the latter type had a 5-year survival rate
of 30%. Multivariate analysis revealed that stage, histology, and KPS
were predictive of overall survival. In Stages III and IV, relapses we
re reduced by postoperative radiotherapy from 50% to 20%. The site of
relapse was outside the irradiated area in 80% of patients. Disease fr
ee survival (P = 0.36) and median survival (P = 0.72) of patients with
completely resected advanced thymomas did not differ from that for pa
tients with incompletely resected tumors who received radiotherapy. CO
NCLUSIONS. Postoperative radiotherapy can improve local control in pat
ients with advanced thymoma. Survival after incomplete resection is no
t compromised when postoperative radiotherapy is employed. KPS should
be considered an important prognostic factor in future studies. Cancer
1998;83:1495-503. (C) 1998 American Cancer Society.